Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
J Clin Oncol Zhu et al. 10.1200/JCO.2007.14.8924

Publisher’s Note

The September 10, 2008, article by Zhu et al entitled, “Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21” (J Clin Oncol 10.1200/JCO.2007.14.8924) was published online July 14, 2008 with an error. The following information was inadvertently omitted from the sidebar:

Supported by grants from the Ontario Institute of Cancer Research, the Canadian Cancer Society/National Cancer Institute of Canada, the Jacqueline Seroussi Memorial Foundation for Cancer Research, and OSI Pharmaceuticals, Inc.

This has been corrected as of July 28, 2008.



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions
About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online